BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32963220)

  • 21. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
    Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H
    Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
    An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
    Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
    Dao R; Wudu M; Hui L; Jiang J; Xu Y; Ren H; Qiu X
    Pathol Res Pract; 2020 Mar; 216(3):152823. PubMed ID: 31983569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
    Liao Y; Cao L; Wang F; Pang R
    J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X; Chen Z
    Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
    Wang P; Deng Y; Fu X
    Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis.
    Li S; Mei Z; Hu HB; Zhang X
    J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.
    Huang Z; Lei W; Hu HB; Zhang H; Zhu Y
    J Cell Physiol; 2018 Oct; 233(10):6768-6776. PubMed ID: 29693721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.
    Li G; Wang K; Wang J; Qin S; Sun X; Ren H
    J Cell Biochem; 2019 Jun; 120(6):10587-10595. PubMed ID: 30816573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
    Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
    EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3-induced upregulation of circCCDC66 facilitates the progression of non-small cell lung cancer by targeting miR-33a-5p/KPNA4 axis.
    Wang Y; Zhao W; Zhang S
    Biomed Pharmacother; 2020 Jun; 126():110019. PubMed ID: 32151944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer.
    Zhu K; Ding H; Wang W; Liao Z; Fu Z; Hong Y; Zhou Y; Zhang CY; Chen X
    Oncotarget; 2016 May; 7(19):28075-85. PubMed ID: 27057632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircRNA_102179 promotes the proliferation, migration and invasion in non-small cell lung cancer cells by regulating miR-330-5p/HMGB3 axis.
    Zhou ZF; Wei Z; Yao JC; Liu SY; Wang F; Wang Z; Chen XF; Lin H; Ye Y; Zheng QF
    Pathol Res Pract; 2020 Nov; 216(11):153144. PubMed ID: 32911346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.